Results 131 to 140 of about 26,466 (239)

Malignancy in Pediatric Hyperfunctioning Thyroid Nodules: A Case Report and Literature Review

open access: yesClinical Endocrinology, Volume 105, Issue 4, Page 474-485, October 2026.
ABSTRACT Background Thyroid nodules are rare in children but carry a markedly higher risk of malignancy compared to adults (20%–26% vs. 5%). Hyperfunctioning thyroid nodules are exceptionally uncommon in the pediatric population and are typically benign.
Cristina Clausi   +12 more
wiley   +1 more source

Pediatric, Adolescent & Young Adult Cancer: Timely, urgent, and essential

open access: yes
Pediatric, Adolescent &Young Adult Cancer, Volume 1, Issue 1, November 2026.
Nirali N. Shah
wiley   +1 more source

International Dermoscopy Society consensus recommendations for the management of lentigo maligna

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1600-1617, October 2026.
Lentigo maligna (LM) poses diagnostic and therapeutic challenges amid rising incidence and limited high‐quality evidence. This international expert consensus provides pragmatic, evidence‐based and expertise‐informed guidance on LM diagnosis and management.
Ana‐Maria Forsea   +52 more
wiley   +1 more source

Adjusted Risk Stratification of Indeterminate Thyroid Nodules Using the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI‐RADS)

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background The TI‐RADS guides the initial management of thyroid nodules, but the malignancy risk across different categories of cytologically indeterminate thyroid nodules (CITNs), particularly AUS and FN, remains unclear. Methods We reviewed thyroid FNA specimens diagnosed as AUS or FN with TI‐RADS scores of 3, 4, or 5 from 2017 to 2025 ...
Jessica Zhao   +8 more
wiley   +1 more source

Cytopathology [PDF]

open access: yesLaboratory Investigation, 2013
Michael T. Sheaff, Naveena Singh
  +5 more sources

Feasibility of routine clinical liquid‐based cytology for lung cancer compact panel testing

open access: yesCancer Cytopathology, Volume 134, Issue 9, September 2026.
Abstract Background The Lung Cancer Compact Panel (cPANEL) is a recently approved highly sensitive multiplex gene panel in Japan that supports both DNA‐ and RNA‐based next‐generation sequencing. Although cytological specimens are acceptable for cPANEL, unfixed cell pellets or dedicated preservation tubes are typically recommended.
Yoshiki Shinomiya   +16 more
wiley   +1 more source

Diagnostic Utility of High Fluorescence Cells in Detecting Malignant Effusions

open access: yesJournal of Cytology
Background: Most modern haematology analysers have a dedicated body fluid mode for cell counts of body fluids. Many analysers also count the number of high fluorescence cells (HF cells).
Shashank Mishra   +2 more
doaj   +1 more source

Interobserver variation among cytopathologists in the evaluation of oncocytic cell‐predominant thyroid FNA cytology: A validation study of 173 cases with surgical follow‐up and correlation with molecular testing

open access: yesCancer Cytopathology, Volume 134, Issue 9, September 2026.
Abstract Background Interpretation of oncocytic cell‐predominant cytologies (OCP) is very challenging as a majority of those cases are diagnosed as indeterminate, including atypia of undetermined significance (AUS) and follicular neoplasm (FN). The authors previously reported a combination of a four‐risk factor model highly predictive of neoplasia and ...
Tarik M. Elsheikh   +5 more
wiley   +1 more source

Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.

open access: yes, 2016
BACKGROUND: Recent discussions have focused on redefining noninvasive follicular variant of papillary thyroid carcinoma (NI-FVPTC) as a neoplasm rather than a carcinoma.
Gourmaud, J.   +10 more
core   +1 more source

The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions

open access: yesDiagnostic Cytopathology, Volume 54, Issue 9, Page 631-636, September 2026.
ABSTRACT Background Mesothelioma is a rare tumor that arises from the serosal cells lining the serous cavities, most commonly the pleura followed by the peritoneum. Presenting symptoms include pleuritic pain and bloody effusions that recur. Although cytologic analysis cannot determine the mesothelial subtype or in situ from invasive disease, the ...
Suzanne M. Selvaggi
wiley   +1 more source

Home - About - Disclaimer - Privacy